Loading
Latest filing published 19 Dec 2022 for Oncodesign Precision Medicine S.A., €123k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Jan HOFLACK is a declared insider at 2 companies (board member); the most frequent names are Oncodesign and Oncodesign Precision Medicine S.A. In total, 2 filings cover trades dated from 18 October 2022 to 8 December 2022.
On the open market, the record shows 1 purchase worth €123k and 1 sale worth €5.2M. Netting one side against the other leaves €5.0M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 19 December 2022 with an open-market purchase (€123k) in Oncodesign Precision Medicine S.A. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations